Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing

BACKGROUND: The high worldwide genetic diversity of HIV poses significant challenges for its detection and diagnosis by nucleic acid testing (NAT). Well-characterized reference panels are important for evaluating the analytical performance of HIV tests. OBJECTIVE: To develop a reference panel for HIV NAT that reflects the genetic diversity of circulating strains. STUDY DESIGN: HIV was cultured from blood specimens collected from blood donor and clinical sites in Cameroon. Metagenomic next-generation sequencing in combination with spiked primer enrichment along with Sanger sequencing were used to sequence 101 cultured HIV-1 samples representing 59 strains. To establish an HIV-1 variant reference panel, a diverse subset of cultured viruses was analyzed in multiple laboratories with different assays to determine consensus viral loads. RESULTS: Near full-length HIV-1 genomes, with an average of 9589 base pairs (bp), were recovered from 37 (62.7%) of the 59 strains. The whole genome sequences of 28 strains exhibited more than 95% similarity to our previously reported genomes obtained by Sanger sequencing. An HIV variant reference panel for NAT comprising 18 diverse HIV-1 strains was developed. The panel included four subtypes, four circulating recombinant forms, and eight unique recombinant forms. Strains were prepared at low (n = 18, 2.53 log10 copies/mL), medium (n = 18, 3.61 log10 copies/mL), and high viral loads (n = 15, 4.66 log10 copies/mL), yielding 51 panel members in total. CONCLUSION: This diverse HIV reference panel can be used to evaluate the performance of HIV NAT and is available upon request to developers and manufacturers of HIV tests.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Virology
Published
2026-04-03
DOI
https://doi.org/10.1016/j.jcv.2026.105941
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing

Viswanath Ragupathy, Jessica A. DeQuach, Hanxia Huang, Alicia Sotomayor-González et al.
Journal of Clinical Virology
HIV/AIDS drug development and treatment
article

Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing

Viswanath Ragupathy, Jessica A. DeQuach, Hanxia Huang, Alicia Sotomayor-González, Santanu Biswas, Charles Y. Chiu, David R. McGivern, Jiangqin Zhao, Cassie Porth, Melissa Hunsicker, Tianxiong Li, Indira Hewlett, Venice Servellita, Oksana Yakovleva, Helene Highbarger, Jose D. Morales, Ethan Sun, Patricia Barilko, Samantha Huynh, Thomas N. Denny, Robin L. Dewar, Xue Wang
article en

Abstract

BACKGROUND: The high worldwide genetic diversity of HIV poses significant challenges for its detection and diagnosis by nucleic acid testing (NAT). Well-characterized reference panels are important for evaluating the analytical performance of HIV tests. OBJECTIVE: To develop a reference panel for HIV NAT that reflects the genetic diversity of circulating strains. STUDY DESIGN: HIV was cultured from blood specimens collected from blood donor and clinical sites in Cameroon. Metagenomic next-generation sequencing in combination with spiked primer enrichment along with Sanger sequencing were used to sequence 101 cultured HIV-1 samples representing 59 strains. To establish an HIV-1 variant reference panel, a diverse subset of cultured viruses was analyzed in multiple laboratories with different assays to determine consensus viral loads. RESULTS: Near full-length HIV-1 genomes, with an average of 9589 base pairs (bp), were recovered from 37 (62.7%) of the 59 strains. The whole genome sequences of 28 strains exhibited more than 95% similarity to our previously reported genomes obtained by Sanger sequencing. An HIV variant reference panel for NAT comprising 18 diverse HIV-1 strains was developed. The panel included four subtypes, four circulating recombinant forms, and eight unique recombinant forms. Strains were prepared at low (n = 18, 2.53 log10 copies/mL), medium (n = 18, 3.61 log10 copies/mL), and high viral loads (n = 15, 4.66 log10 copies/mL), yielding 51 panel members in total. CONCLUSION: This diverse HIV reference panel can be used to evaluate the performance of HIV NAT and is available upon request to developers and manufacturers of HIV tests.

Journal of Clinical VirologyVol. 184
Naval Medical Research Command (US), United States Food and Drug Administration (US), Duke University (US), University of California, San Francisco (US), Integrated Dynamic Electron Solutions (United States) (US), Hologic (United States) (US), Frederick National Laboratory for Cancer Research (US), Science Applications International Corporation (United States) (US)
U.S. Department of Health and Human Services, National Institutes of Health, U.S. Food and Drug Administration, University of California, San Francisco, Center of Excellence in Regulatory Science and Innovation, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 32%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.